CIK 0001665988 · Accelerated filer<br>Emerging growth company
Bioventus Inc.
Sign in to watch- Ticker
- BVS
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 810980861
- Phone
- (919) 474-6700
- Business address
- 4721 EMPEROR BOULEVARD, SUITE 100, DURHAM, NC, 27703
- 4 Option exercise Director acquired 30,400 shares (option exercise)
- 4 Option exercise Director acquired 7,576 shares (option exercise)
- DEFA14A Proxy Proxy Materials
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Planned sale SVP & CFO sold 4,000 shares at $4.75 ($19,000)
- 4 Planned sale SVP & General Counsel sold 3,054 shares at $4.75 ($14,507)
- 4 Planned sale SVP & Chief Compliance Officer sold 1,325 shares at $4.75 ($6,294)
- 4 Option exercise SVP & CFO acquired 13,000 shares (option exercise)
- 4 Option exercise SVP & General Counsel acquired 9,925 shares (option exercise)
- 4 Option exercise SVP & Chief Compliance Officer acquired 4,300 shares (option exercise)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- PRE 14A Proxy Proxy Statement (Preliminary)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
Page 9 of 24 · 463 filings